Skip to content

All recalls CPSC

CPSCConsumer productsRecalled Status: Ongoing

Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Highest. risk

Estimated risk

CPSC doesn't classify recalls by risk, so Recall Relay estimated the risk as high from the hazard description. This is our estimate, not an official classification.

Hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
What to do
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Products
  • Mamisan Pain Relieving Topical Ointment
Companies
Plantimex, MiramarLab, Plantimex Distributors, Inc.
Where it was sold

Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.

Nationwide

Barcodes
860006498115
Units affected
About 50,330
About this recall
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.